(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KINIKSA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KINIKSA

ST13

US500000086765893

Class

5

Filing

86765893

Registration

5566176

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

04/10/2026

Trademark type

Word

Nice classes

5

Filing date

09/23/2015

Registration date

09/18/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/02/2025

Last transaction

04/10/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/15/2017

First use in commerce

11/15/2017

Drawing code

4

Owner type

83

Owner location

LONDON, GB

Examiner

VERHOSEK, WILLIAM T

Current location

Historical data usage

Holders and representatives

Holders

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.
Kiniksa Pharmaceuticals, Ltd.

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of pruritus; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders

Publications

History of USPTO decisions and trademark events.

37 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/11/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/02/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/02/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/02/2025

E815

TEAS SECTION 8 & 15 RECEIVED

08/02/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/18/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/18/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/15/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/14/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/06/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/06/2018

IUAF

USE AMENDMENT FILED

07/11/2018

EISU

TEAS STATEMENT OF USE RECEIVED

07/11/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/10/2018

EX2G

SOU EXTENSION 2 GRANTED

04/06/2018

EXT2

SOU EXTENSION 2 FILED

04/06/2018

EEXT

SOU TEAS EXTENSION RECEIVED

04/06/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/16/2017

EX1G

SOU EXTENSION 1 GRANTED

09/14/2017

EXT1

SOU EXTENSION 1 FILED

09/14/2017

EEXT

SOU TEAS EXTENSION RECEIVED

09/14/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/11/2017

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

02/28/2017

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

09/13/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/16/2016

PUBO

PUBLISHED FOR OPPOSITION

08/16/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/27/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/14/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/08/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/12/2016

GNRT

NON-FINAL ACTION E-MAILED

01/12/2016

CNRT

NON-FINAL ACTION WRITTEN

01/12/2016

DOCK

ASSIGNED TO EXAMINER

01/11/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2015

NWAP

NEW APPLICATION ENTERED

09/26/2015

Continuous trademark protection

Get notified about every new filing that threatens KINIKSA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.